<DOC>
	<DOCNO>NCT02839473</DOCNO>
	<brief_summary>The primary objective consist avoid deterioration and/or restore integrity skin patient treat radiotherapy , right first sign grade 1 2 radiation dermatitis .</brief_summary>
	<brief_title>HydrosorbÂ® Versus Control Management Radio-induced Skin Toxicity : Multicentre Controlled Phase III Randomized Trial</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<criteria>Women treat normo fractionate radiotherapy breast cancer Presenting grade 1 2 radiation dermatitis treatment provide write informed consent include study . Exclusion criterion : Were male patient Radiation dermatitis already treat cause another treatment Subjects deprive freedom guardianship Subjects medical followup impossible A cancer wound skin flap irradiate zone A history allergic skin reaction Concomitant chemotherapy concomitant bevacizumab therapy bilateral irradiation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>